|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01447654 |
|
Date of registration:
|
04/10/2011 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy
INHERIT |
|
Scientific title:
|
INHibition of the Renin Angiotensin System in Hypertrophic Cardiomyopathy and the Effect on Ventricular Hypertrophy - a Randomized Intervention Trial With Losartan. |
|
Date of first enrolment:
|
November 2011 |
|
Target sample size:
|
130 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01447654 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Hypertrophic cardiomyopathy
- > 18 years
- Sinus rhythm
Exclusion Criteria:
- EF < 50 %
- Treatment with RAS-inhibitor
- Contraindications to losartan
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypertrophic Cardiomyopathy
|
|
Intervention(s)
|
|
Drug: Placebo
|
|
Drug: Losartan
|
|
Primary Outcome(s)
|
|
Hypertrophy of left ventricle
[Time Frame: 12 months]
|
|
Secondary ID(s)
|
|
2011-001191-19
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|